HD-OPM Archive
Topics › Aging & longevity

Lowering IGF1 might extend lifespan in dogs and perhaps humans

Louis Nervegna · Jun 04, 2026 · ♥ 6 reactions · 3 comments · original Facebook post
Aging & longevity
AI summary & key facts

Short post pointing to Loyal's IGF1-lowering dog drug and suggesting interventions that lower IGF1 might reduce heart disease, diabetes, cancer and Alzheimer's risk. Claims are speculative and based on the company's own statements.

Drugs (and other interventions) that lower IGF1 might extend lifespan in dogs, and maybe humans as well.

They may lower risk for heart disease, diabetes, cancer, and Alzheimer’s.

See this post:
↪ Lowering IGF1 extends lifespan in mice, so be wary of 'anti-aging' growth hormone claims

An early stage Silicon Valley biotech company, called Loyal, says that their IGF1 lowering drug will be available for use in dogs by the end of the year.

They claim that it extends the lifespan of dogs.

#igf1HD #loyalHD #dogsHD #agingHD #longevityHD #growthhormoneHD

← newer: Loyal raised $125M for an IGF1-lowering longevity drug for dolder: Lowering IGF1 extends lifespan in mice, so be wary of 'anti- →